Here's a reminder of the day he first suggested bleach injections and UV light - inside the body :) The most recent information from Synairgen suggests that the trial finance is in place ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Shares in UK biotech Synairgen have dived after AstraZeneca halted a phase 2a trial for its asthma drug, AZD9412, because it had failed to generate efficacy data. Southampton-based Synairgen ...

UK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after encouraging topline results from a phase 2 study that started last March.

At close: November 8 at 3:00 PM EST ...

DRUG Bright Minds Biosciences Inc.

As of 10:56 BST. Market open. There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...

Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including ...